Drugs / YH23537
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02759198 | May 2016 → May 2017 | osteoarthritis, knee | Yuhan Corporation | Completed | No outcome recorded |
| Phase 2 | NCT02585596 | Dec 2015 → Dec 2016 | chronic periodontitis | Yuhan Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YH23537 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02759198 ↗ |
| Route | Oral | “Following 12-week Oral Administration” NCT02585596 ↗ |